BSE: ZYDUSLIFE - Zydus Lifesciences Limited

Rentabilidade por seis meses: -8.83%
Setor: Healthcare

Cronograma de promoção Zydus Lifesciences Limited


Sobre a empresa

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, Europe, Latin America, the Asia Pacific, and Africa. The company operates in Pharmaceuticals and Consumer Products segments.

mais detalhes
It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; and products in the therapeutic areas of pain management, neurology, dermatology, liver diseases, and other areas. The company also provides consumer wellness products, such as Complan; EverYuth, a range of skincare products; Nycil; Glucon-D glucose powder; Nutralite; Nutralite Doodhshakti, a portfolio of dairy products; and various other products. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is based in Ahmedabad, India.

ISIN INE010B01027
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 1.34
Дивиденд ао 6
Сайт https://zyduslife.com
Цена ао 1054.35
Alteração de preço por dia: +1.37% (959.55)
Alteração de preço por semana: -0.1232% (973.9)
Alteração de preço por mês: +2.31% (950.7)
Alteração de preço em 3 meses: -9.48% (1074.6)
Mudança de preço em seis meses: -8.83% (1066.95)
Mudança de preço por ano: +41.75% (686.2)
Mudança de preço em 3 anos: +119.03% (444.1)
Mudança de preço em 5 anos: +332.98% (224.65)
Mudança de preço em 10 anos: 0% (972.7)
Mudança de preço desde o início do ano: +0.6779% (966.15)

Subestimação

Nome Significado Nota
P/S 5.29 2
P/BV 4.55 3
P/E 26.06 6
EV/EBITDA 14.65 7
Total: 5

Eficiência

Nome Significado Nota
ROA, % 14.03 4
ROE, % 20.67 7
Total: 4.17

Dividendos

Nome Significado Nota
Div yield, % 0.7249 1.8
DSI 0.8571 8.57
Total: 2.58

Obrigação

Nome Significado Nota
Debt/EBITDA 0 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 37.72 5
Rentabilidade Ebitda, % 36.84 5
Rentabilidade EPS, % 233.73 10
Total: 7.2



Supervisor Cargo Pagamento Ano de nascimento
Dr. Sharvil Pankajbhai Patel MD & Executive Director 262.5M 1979 (46 anos)
Dr. Ganesh Narayan Nayak COO & Executive Director 120M 1955 (70 anos)
Mr. Punit Patel President & CEO of America N/A
Mr. Nitinkumar Dalsukhray Parekh Chief Financial Officer 54.31M
Mr. Arvind Bothra Head of Investor Relations N/A
Mr. Dhaval Narendra Soni Company Secretary & Compliance Officer 2.09M

Endereço: India, Ahmedabad, Zydus Corporate Park - abrir no Google Maps, abrir mapas Yandex
Site: https://zyduslife.com